文献速递湿疹皮炎与荨麻疹

湿疹自我管理干预的系统综述

Systematic review of self-management interventions for people with eczema.
PubMed 文献 · Br J Dermatol · 2017-08-02

该研究系统检索了从建库至2016年8月的随机对照试验,评估促进成人和儿童湿疹自我管理的干预措施。共纳入20项研究(3028名参与者),多数在二级医疗机构进行且针对儿童。研究报告质量普遍较差,有效性证据有限,且缺乏成本效果分析,因此如何以临床有效且成本效果好的方式支持湿疹自我管理仍不确定。

要点

  • 纳入20项研究,多数针对儿童且于二级医疗机构开展,随访多为短期。
  • 干预以面对面教育为主,有效性证据有限,仅1项研究进行正式成本效果分析。
  • 现有随机对照试验设计和报告质量普遍较差,未来需更高质量研究。

核心结论

  • 目前缺乏设计和报告良好、理论基础的随机对照试验,湿疹自我管理的最佳支持方式仍不确定。

研究设计与样本

  • 系统综述检索MEDLINE、MEDLINE in process、Embase、CINAHL和Global Resource for EczemA Trials数据库,从建库至2016年8月,纳入随机对照试验。
  • 共纳入20项研究,3028名参与者,来自11个国家。

主要发现

  • 多数研究(n=18)在二级医疗机构进行,大多数(n=16)针对儿童湿疹。
  • 多数研究(n=12)随访为短期(至12周),仅6项试验指定单一主要结局。
  • 有效性证据有限,仅3项研究收集并报告成本相关结局,仅1项研究进行正式成本效果分析。

局限性

  • 研究报告普遍较差,包括干预措施和结局的描述。
  • 仅少数研究评估成本效果,长期效果证据不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Eczema is a common long-term condition, but inadequate support and information can lead to poor adherence and treatment failure. We have reviewed the international literature of interventions designed to promote self-management in adults and children with eczema. MEDLINE, MEDLINE in process, Embase, CINAHL and the Global Resource for EczemA Trials database were searched from their inception to August 2016, for randomized controlled trials. Two authors independently applied eligibility criteria, assessed risk of bias for all included studies and extracted data. Twenty studies (3028 participants) conducted in 11 different countries were included. The majority (n = 18) were based in secondary care and most (n = 16) targeted children with eczema. Reporting of studies, including descriptions of the interventions and the outcomes themselves, was generally poor. Thirteen studies were face-to-face educational interventions, five were delivered online and two were studies of written action plans. Follow-up in most studies (n = 12) was short term (up to 12 weeks). Only six trials specified a single primary outcome. There was limited evidence of effectiveness. Only three studies collected and reported outcomes related to cost and just one study undertook any formal cost-effectiveness analysis. In summary, we have identified a general absence of well-conducted and well-reported randomized controlled trials with a strong theoretical basis. Therefore, there is still uncertainty about how best to support self-management of eczema in a clinically effective and cost-effective way. Recommendations on design and conduct of future trials are presented.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Ridd MJ, King AJL, Le Roux E, et al. Systematic review of self-management interventions for people with eczema. Br J Dermatol. 2017. PMID: 28432696. doi:10.1111/bjd.15601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。